» Articles » PMID: 33682732

The α-Synuclein Origin and Connectome Model (SOC Model) of Parkinson's Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline

Overview
Publisher Sage Publications
Specialty Neurology
Date 2021 Mar 8
PMID 33682732
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

A new model of Parkinson's disease (PD) pathogenesis is proposed, the α-Synuclein Origin site and Connectome (SOC) model, incorporating two aspects of α-synuclein pathobiology that impact the disease course for each patient: the anatomical location of the initial α-synuclein inclusion, and α-synuclein propagation dependent on the ipsilateral connections that dominate connectivity of the human brain. In some patients, initial α-synuclein pathology occurs within the CNS, leading to a brain-first subtype of PD. In others, pathology begins in the peripheral autonomic nervous system, leading to a body-first subtype. In brain-first cases, it is proposed that the first pathology appears unilaterally, often in the amygdala. If α-synuclein propagation depends on connection strength, a unilateral focus of pathology will disseminate more to the ipsilateral hemisphere. Thus, α-synuclein spreads mainly to ipsilateral structures including the substantia nigra. The asymmetric distribution of pathology leads to asymmetric dopaminergic degeneration and motor asymmetry. In body-first cases, the α-synuclein pathology ascends via the vagus to both the left and right dorsal motor nuclei of the vagus owing to the overlapping parasympathetic innervation of the gut. Consequently, the initial α-synuclein pathology inside the CNS is more symmetric, which promotes more symmetric propagation in the brainstem, leading to more symmetric dopaminergic degeneration and less motor asymmetry. At diagnosis, body-first patients already have a larger, more symmetric burden of α-synuclein pathology, which in turn promotes faster disease progression and accelerated cognitive decline. The SOC model is supported by a considerable body of existing evidence and may have improved explanatory power.

Citing Articles

Sympathetic and parasympathetic subtypes of body-first Lewy body disease observed in postmortem tissue from prediagnostic individuals.

Andersen K, Krishnamurthy A, Just M, Van Den Berge N, Skjaerbaek C, Horsager J Nat Neurosci. 2025; .

PMID: 40082617 DOI: 10.1038/s41593-025-01910-9.


Convergent reductions in interhemispheric functional, structural and callosal connectivity in Parkinson's disease.

Wang E, Jia Y, Cheng L, Mao C, Bao Y, Shen J Front Aging Neurosci. 2025; 17:1512130.

PMID: 40018517 PMC: 11865091. DOI: 10.3389/fnagi.2025.1512130.


Cholinergic degeneration and early cognitive signs in prodromal Lewy body dementia.

Woo K, Kim H, Kim R, Jin B, Shin J, Kim S Alzheimers Dement. 2025; 21(2):e14584.

PMID: 39985502 PMC: 11846479. DOI: 10.1002/alz.14584.


Bradykinesia and postural instability in a model of prodromal synucleinopathy with α-synuclein aggregation initiated in the gigantocellular nuclei.

Theologidis V, Ferreira S, Jensen N, Gomes Moreira D, Ahlgreen O, Hansen M Acta Neuropathol Commun. 2025; 13(1):32.

PMID: 39962601 PMC: 11834571. DOI: 10.1186/s40478-025-01948-7.


Substantia nigra and locus coeruleus microstructural abnormalities in isolated rapid eye movement sleep behaviour disorder and Parkinson's disease.

Pasquini J, Firbank M, Best L, Foster V, Stewart C, Silani V Brain Commun. 2025; 7(1):fcaf023.

PMID: 39926608 PMC: 11806417. DOI: 10.1093/braincomms/fcaf023.


References
1.
Braak H, Del Tredici K, Rub U, de Vos R, Jansen Steur E, Braak E . Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2002; 24(2):197-211. DOI: 10.1016/s0197-4580(02)00065-9. View

2.
Cheng H, Ulane C, Burke R . Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol. 2010; 67(6):715-25. PMC: 2918373. DOI: 10.1002/ana.21995. View

3.
Zhang X, Renehan W, Fogel R . Vagal innervation of the rat duodenum. J Auton Nerv Syst. 2000; 79(1):8-18. DOI: 10.1016/s0165-1838(99)00093-4. View

4.
LaMantia A, Rakic P . Cytological and quantitative characteristics of four cerebral commissures in the rhesus monkey. J Comp Neurol. 1990; 291(4):520-37. DOI: 10.1002/cne.902910404. View

5.
Szatmari Jr S, Ajtay A, Oberfrank F, Dobi B, Bereczki D . The prevalence of psychiatric symptoms before the diagnosis of Parkinson's disease in a nationwide cohort: A comparison to patients with cerebral infarction. PLoS One. 2020; 15(8):e0236728. PMC: 7402492. DOI: 10.1371/journal.pone.0236728. View